Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Dec 15;126(24):5328-5336.
doi: 10.1002/cncr.33186. Epub 2020 Sep 30.

Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3-arm randomized trial

Affiliations
Randomized Controlled Trial

Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3-arm randomized trial

Mélanie Dos Santos et al. Cancer. .

Abstract

Background: There is no treatment for cancer-related cognitive impairment, an important adverse effect that negatively impacts quality of life (QOL). We conducted a 3-arm randomized controlled trial to evaluate the impact of computer-assisted cognitive rehabilitation (CR) on cognition, QOL, anxiety, and depression among cancer patients treated with chemotherapy.

Methods: Patients who reported cognitive complaints during or after completing chemotherapy were randomly assigned to 1 of 3 12-week CR programs: computer-assisted CR with a neuropsychologist (experimental group A), home cognitive self-exercises (active control group B), or phone follow-up (active control group C). Subjective cognition was assessed by the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog), objective cognition was assessed by neuropsychological tests, QOL was assessed by the FACT-General, and depression and anxiety were assessed by psychological tests. The primary endpoint was the proportion of patients with a 7-point improvement in the FACT-Cog perceived cognitive impairment (PCI) score.

Results: Among the 167 enrolled patients (median age, 51 years), group A had the highest proportion of patients with a 7-point PCI improvement (75%), followed by groups B (59%) and C (57%), but the difference was not statistically significant (P = .13). Compared with groups B and C, the mean difference in PCI score was significantly higher in group A (P = .02), with better perceived cognitive abilities (P < .01) and a significant improvement in working memory (P = .03). Group A reported higher QOL related to cognition (FACT-Cog QOL) (P = .01) and improvement in depression symptoms (P = .03).

Conclusions: These results suggest a benefit of a computer-based CR program in the management of cancer-related cognitive impairment and complaints.

Keywords: cancer; chemotherapy; cognitive impairment; cognitive rehabilitation; supportive care.

PubMed Disclaimer

Conflict of interest statement

The authors made no disclosures.

Figures

Figure 1
Figure 1
CONSORT flow diagram. CR, cognitive rehabilitation.
Figure 2
Figure 2
Forest plot of effect sizes and 95% CIs for computer‐assisted cognitive rehabilitation compared with the 2 active control groups. CES‐D, Center for Epidemiologic Studies Depression Scale; CR, cognitive rehabilitation; ES, effect size; FACT‐An, Functional Assessment of Cancer Therapy–Anemia; FACT‐G, Functional Assessment of Cancer Therapy–General; PCA, perceived cognitive abilities; PCI, perceived cognitive impairments; STAI‐Trait, Spielberger State‐Trait Anxiety Inventory; WAIS, Wechsler Adult Intelligence Scale.

References

    1. Myers JS. Cancer‐ and chemotherapy‐related cognitive changes: the patient experience. Semin Oncol Nurs. 2013;29:300‐307. doi:10.1016/j.soncn.2013.08.010 - DOI - PubMed
    1. Joly F, Giffard B, Rigal O, et al. Impact of cancer and its treatments on cognitive function: advances in research from the Paris International Cognition and Cancer Task Force Symposium and update since 2012. J Pain Symptom Manage. 2015;50:830‐841. doi:10.1016/j.jpainsymman.2015.06.019 - DOI - PubMed
    1. Vardy J, Dhillon H. The fog hasn't lifted on “chemobrain” yet: ongoing uncertainty regarding the effects of chemotherapy and breast cancer on cognition. Breast Cancer Res Treat. 2010;123:35‐37. doi:10.1007/s10549-009-0719-0 - DOI - PubMed
    1. Lange M, Licaj I, Clarisse B, et al. Cognitive complaints in cancer survivors and expectations for support: results from a web‐based survey. Cancer Med. 2019;8:2654‐2663. - PMC - PubMed
    1. Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA. A prospective longitudinal study of chemotherapy‐induced cognitive changes in breast cancer patients. Support Care Cancer. 2011;19:1647‐1656. doi:10.1007/s00520-010-0997-4 - DOI - PubMed

Publication types

Substances

Grants and funding